Pfizer (PFE) Tops Q1 EPS by 15c, Raises FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.93 +0.68%
Revenue Growth %: -4.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -4.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.93, $0.15 better than the analyst estimate of $0.78. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.6 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.55-$3.65, versus the consensus of $3.36. Pfizer sees FY2021 revenue of $70.5-72.5 billion, versus the consensus of $62.99 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- HP Inc. projects mid-single-digit PC market decline in 2027
- Bernstein SocGen Group Starts Amphenol (APH) at Outperform
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
